Clinical Cell Culture renames
Tuesday, 10 June, 2008
Clinical Cell Culture (ASX: CCE) is to be re-named Avita Medical following a shareholder meeting.
The resolution to change the company's name was passed by the vast majority of shareholders.
Shareholders have also resolved to consolidate the company's shares on a 10:1 basis.
The company believes that a name change and the recent shake-up of the boardroom will help drive sales of the company's products, such as the ReCell autologous skin cell kit, further.
Defective sperm doubles pre-eclampsia risk in IVF patients
A high proportion of the father's spermatozoa possessing DNA strand breaks is associated with...
Free meningococcal B vaccines coming to the NT
The Northern Territory Government has confirmed the rollout of a free meningococcal B vaccine...
Mouth bacteria linked to increased head and neck cancer risk
More than a dozen bacterial species that live in people's mouths have been linked to a...
